Product image of Luxturna (Voretigene Neparvovec) supplied by GNH India

Luxturna

Active Ingredient:
Voretigene Neparvovec
Origin:
EU

Luxturna (Voretigene Neparvovec)

Luxturna (Voretigene Neparvovec) is a gene therapy designed for treating inherited retinal diseases. This innovative treatment targets specific genetic mutations to potentially restore vision.

Manufacturer / TM Owner

Novartis Europharm Limited

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Luxturna is used for the treatment of inherited retinal dystrophy caused by mutations in the RPE65 gene. This condition leads to progressive vision loss. Luxturna aims to address the underlying genetic cause of the disease, offering a potential solution for those affected by this rare condition.

Side Effects

  • Luxturna works by delivering a functional copy of the RPE65 gene to the retinal cells. This process aims to restore vision in individuals with this specific genetic mutation. The effects of Luxturna can vary, and patients should consult their healthcare provider for personalized information.

Precautions & Warnings

  • Luxturna is administered via subretinal injection, which is a complex procedure. It is important to discuss potential risks and benefits with a healthcare professional. Patients should also be aware of any allergies or sensitivities to the components of the therapy.

Avoid Interactions

  • As with any medical treatment, interactions with other medications or therapies should be considered. Patients should inform their healthcare provider about all current medications and treatments before undergoing Luxturna therapy.

Frequently Asked Questions

Luxturna is used to treat inherited retinal dystrophy caused by mutations in the RPE65 gene, which can lead to progressive vision loss.

Luxturna delivers a functional copy of the RPE65 gene to retinal cells, aiming to restore vision in individuals with this specific genetic mutation.

Potential side effects of Luxturna may include inflammation, increased eye pressure, and other complications related to the subretinal injection procedure.

Candidates for Luxturna therapy are individuals diagnosed with inherited retinal dystrophy due to RPE65 gene mutations, as determined by a healthcare professional.

Luxturna's availability varies by country and is subject to regulatory approvals. Patients should consult their healthcare provider for information specific to their location.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Voretigene Neparvovec

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT